Philogen SpA (MIL:PHIL) Total Liabilities: €63.5 Mil (As of Dec. 2025)


MIL:PHIL Philogen SpA MIL:PHIL
59 GF Score
Price €23.20
GF Value €227.22
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Philogen SpA Total Liabilities?

Philogen SpA MIL:PHIL -0.22% 59 Total Liabilities is €63.5 Mil as of Dec. 2025. GuruFocus rates MIL:PHIL with a GF Score™ of 59/100 and a GF Value™ of €227.22 (Possible Value Trap). The stock has 3 warning signs investors should review.

Philogen SpA's Total Liabilities for the quarter that ended in Dec. 2025 was €63.5 Mil.

Philogen SpA's quarterly Total Liabilities increased from Dec. 2024 (€29.80 Mil) to Jun. 2025 (€33.54 Mil) and increased from Jun. 2025 (€33.54 Mil) to Dec. 2025 (€63.46 Mil).

Philogen SpA's annual Total Liabilities increased from Dec. 2023 (€28.68 Mil) to Dec. 2024 (€29.80 Mil) and increased from Dec. 2024 (€29.80 Mil) to Dec. 2025 (€63.46 Mil).


Philogen SpA Total Liabilities Historical Data

* Premium members only.

The historical data trend for Philogen SpA's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Philogen SpA Total Liabilities Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 27.67 27.91 28.68 29.80 63.46

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.68 28.95 29.80 33.54 63.46
MIL:PHIL
59GF Score
Philogen SpA MIL:PHIL
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Philogen SpA Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Philogen SpA's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=51.289+(9.719+1.123
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+1.33+0)
=63.5

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=437.328-373.867
=63.5

Philogen SpA's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=51.289+(9.719+1.123
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+1.33+0)
=63.5

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=437.328-373.867
=63.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €63.5 Mil mean?
Philogen SpA (MIL:PHIL) has a Total Liabilities of €63.5 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Philogen SpA and its competitors.
Is Philogen SpA's Total Liabilities too high?
Philogen SpA's current Total Liabilities is €63.5 Mil. Overall, Philogen SpA has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Philogen SpA's Total Liabilities compare to VRTX and REGN?
Philogen SpA's Total Liabilities of €63.5 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Philogen SpA and its competitors. Philogen SpA's current Total Liabilities is €63.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Philogen SpA stock overvalued right now?
Based on GuruFocus' analysis, Philogen SpA (MIL:PHIL) is currently considered Possible Value Trap. The stock's GF Value™ is €227.22, compared to a current price of €23.20 — trading 89.8% below its estimated fair value. The current Total Liabilities is €63.5 Mil. Philogen SpA's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Philogen SpA (MIL:PHIL), the current Total Liabilities is €63.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Philogen SpA (MIL:PHIL) Overvalued in 2026?

Based on GuruFocus' analysis, Philogen SpA stock appears to be undervalued. The current stock price of €23.20 is trading 89.8% below its estimated GF Value™ of €227.22. GuruFocus considers Philogen SpA to be Possible Value Trap.

Key valuation signals for MIL:PHIL:

  • Total Liabilities: €63.5 Mil
  • GF Value™: €227.22 vs. price of €23.20 (89.8% below fair value)
  • GF Score™: 59/100 with 3 warning signs

No single metric tells the full story. See the MIL:PHIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Philogen SpA Business Description

Other Exchanges 78Q:Germany
Address Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company engaged in the research and development of antibody-based therapeutics for the treatment of cancer and chronic inflammatory diseases. The company's pipeline includes products such as Nidlegy, Fibromun, Darleukin, and Dekavil, targeting oncology and other serious conditions. Geographically, the company operates in the European Union, Switzerland, and the United States of America.
59GF Score

Get the complete analysis for MIL:PHIL

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.20
Price
€227.22
GF Value